This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shao, G. Articles by Zhao, Y. Search for Related Content PubMed PubMed Citation Articles by Shao, G. Articles by Zhao, Y.

Epigenetic Inactivation of Betaig-h3 Gene in Human Cancer Cells

¹ Center for Radiological Research and ² Department of Pathology, Columbia University, New York, New York

Requests for reprints: Yongliang Zhao, Center for Radiological Research, Columbia University, VC11-227, 630 West 168th Street, New York, NY 10032. Phone: 212-305-9981; Fax: 212-305-3229; E-mail: yz93{at}columbia.edu.

Gene silencing by CpG island methylation in the promoter region is one of the mechanisms by which tumor suppressor genes are inactivated in human cancers. It has been shown previously that Betaig-h3 gene, which encodes an extracellular matrix protein involved in cell adhesion and tumorigenesis, is down-regulated or silenced in a variety of human cancer cell lines. To unravel the underlying molecular mechanism(s) for this phenomenon, DNA methylation patterns of Betaig-h3 CpG island were examined in normal, immortalized, and cancer cell lines derived from lung, prostate, mammary, and kidney. A good correlation was observed between promoter hypermethylation and lost expression of Betaig-h3 gene, which was supported by the data that demethylation of promoter by 5-aza-2'-deoxycytidine reactivated Betaig-h3 and restored its expression in Betaig-h3-silenced tumor cell lines. This result was further substantiated by a luciferase reporter assay, showing the restoration of promoter activities and increased response to transforming growth factor-ß treatment in Betaig-h3-negative 293T cells when transfected with unmethylated Betaig-h3 promoter. In contrast, activity of Betaig-h3 promoter was completely inactivated by in vitro methylation. Furthermore, CpG methylation of Betaig-h3 promoter was also shown in primary lung tumors that expressed decreased level of Betaig-h3 protein. These results suggest that promoter methylation plays a critical role in promoter silencing of the Betaig-h3 gene in human tumor cells. (Cancer Res 2006; 66(9): 4566-73)

This article has been cited by other articles:

				A. Zhu, C. X. Zhang, and H. B. Lieberman Rad9 Has a Functional Role in Human Prostate Carcinogenesis Cancer Res., March 1, 2008; 68(5): 1267 - 1274. [Abstract] [Full Text] [PDF]

				Q. Xue, Z. Lin, Y.-H. Cheng, C.-C. Huang, E. Marsh, P. Yin, M. P Milad, E. Confino, S. Reierstad, J. Innes, et al. Promoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis Biol Reprod, October 1, 2007; 77(4): 681 - 687. [Abstract] [Full Text] [PDF]

				Q. Xue, Z. Lin, P. Yin, M. P. Milad, Y.-H. Cheng, E. Confino, S. Reierstad, and S. E. Bulun Transcriptional Activation of Steroidogenic Factor-1 by Hypomethylation of the 5' CpG Island in Endometriosis J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3261 - 3267. [Abstract] [Full Text] [PDF]

				M. A. Partridge, S. X.L. Huang, E. Hernandez-Rosa, M. M. Davidson, and T. K. Hei Arsenic Induced Mitochondrial DNA Damage and Altered Mitochondrial Oxidative Function: Implications for Genotoxic Mechanisms in Mammalian Cells Cancer Res., June 1, 2007; 67(11): 5239 - 5247. [Abstract] [Full Text] [PDF]